These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38351782)

  • 1. Clinical profile of levodopa-carbidopa-entacapone intestinal gel infusion in patients with advanced Parkinson's disease.
    Atanasova-Ivanova KA; Hristova-Chakmakova SI; Milanov IG
    Folia Med (Plovdiv); 2023 Dec; 65(6):929-932. PubMed ID: 38351782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis.
    Liao X; Wu N; Liu D; Shuai B; Li S; Li K
    Neurol Sci; 2020 Aug; 41(8):2045-2054. PubMed ID: 32162166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
    Kuoppamäki M; Leinonen M; Poewe W
    J Neural Transm (Vienna); 2015 Dec; 122(12):1709-14. PubMed ID: 26347184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
    Brooks DJ; Agid Y; Eggert K; Widner H; Ostergaard K; Holopainen A;
    Eur Neurol; 2005; 53(4):197-202. PubMed ID: 15970632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.
    Reichmann H; Emre M
    Expert Rev Neurother; 2012 Feb; 12(2):119-31. PubMed ID: 22288667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study.
    Senek M; Nielsen EI; Nyholm D
    Mov Disord; 2017 Feb; 32(2):283-286. PubMed ID: 27987231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entacapone/levodopa/carbidopa combination tablet: Stalevo.
    Drugs R D; 2003; 4(5):310-1. PubMed ID: 12952501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
    Fung VS; Herawati L; Wan Y; ;
    Mov Disord; 2009 Jan; 24(1):25-31. PubMed ID: 18846551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
    Castro A; Valldeoriola F; Linazasoro G; Rodriguez-Oroz MC; Stochi F; Marin C; Rodriguez M; Vaamonde J; Jenner P; Alvarez L; Pavon N; Macias R; Luquin MR; Hernandez B; Grandas F; Gimenez-Roldan S; Tolosa E; Obeso JA
    Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of oral entacapone administration in patients undergoing levodopa-carbidopa intestinal gel treatment.
    Miyaue N; Ito Y; Yamanishi Y; Tada S; Ando R; Yabe H; Nagai M
    J Neurol Sci; 2024 Feb; 457():122901. PubMed ID: 38280299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease.
    Martínez-Martín P; Hernández B; Ricart J;
    Neurologia; 2014 Apr; 29(3):153-60. PubMed ID: 23465686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania].
    Szász JA; Szatmári S; Constantin V; Mihály I; Rácz A; Domokos LC; Vajda T; Orbán-Kis K
    Orv Hetil; 2019 Apr; 160(17):662-669. PubMed ID: 31010306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Levodopa Formulations for Parkinson's Disease.
    Freitas ME; Ruiz-Lopez M; Fox SH
    CNS Drugs; 2016 Nov; 30(11):1079-1095. PubMed ID: 27743318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selection of the optimal device-aided therapy in Parkinson's disease].
    Kovács N; Aschermann Z; Juhász A; Harmat M; Pintér D; Janszky J
    Ideggyogy Sz; 2019 Jan; 72(1-2):5-11. PubMed ID: 30785241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion Therapies in the Treatment of Parkinson's Disease.
    van Laar T; Chaudhuri KR; Antonini A; Henriksen T; Trošt M
    J Parkinsons Dis; 2023; 13(5):641-657. PubMed ID: 37334617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients.
    Stocchi F; Hsu A; Khanna S; Ellenbogen A; Mahler A; Liang G; Dillmann U; Rubens R; Kell S; Gupta S
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1335-40. PubMed ID: 25306200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease: A Single-Center Study of 30 Patients.
    Viljaharju V; Mertsalmi T; Pauls KAM; Koivu M; Eerola-Rautio J; Udd M; Pekkonen E
    Mov Disord Clin Pract; 2024 Feb; 11(2):159-165. PubMed ID: 38386490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
    Hauser RA; Panisset M; Abbruzzese G; Mancione L; Dronamraju N; Kakarieka A;
    Mov Disord; 2009 Mar; 24(4):541-50. PubMed ID: 19058133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients.
    Müller T; Schlegel E; Zingler S; Thiede HM
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from sustained release carbidopa/levodopa to carbidopa/levodopa/entacapone (stalevo) in Parkinson disease patients.
    Lyons KE; Pahwa R
    Clin Neuropharmacol; 2006; 29(2):73-6. PubMed ID: 16614538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.